View Older Stories View More Recent Stories
-
BTIG Downgrades Tscan Therapeutics Inc (TCRX) to Neutral
-
JELD-WEN cuts 11% of workforce
-
JELD-WEN Reports Third Quarter 2025 Results, Announces Workforce Reductions and Significant Strategic Actions
-
CNO Financial Group Reports Third Quarter 2025 Results
-
TrueBlue Reports Third Quarter 2025 Results
-
SLB launches new AI product as it focuses on digital sales growth
-
VERSES Announces Financing Agreement with a Notional Value of CAD$14 Million and Reduces Staff to Streamline Operations
-
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025
-
Iovance reports 26% response rate in lung cancer trial
-
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
-
TScan reaches FDA agreement on pivotal study design for TSC-101
-
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027
-
US economy at risk of wobble as lower-income consumers get squeezed
-
Euro zone manufacturing stagnates in October amid weak demand, PMI shows
-
GTT : Q3 2025 Activity Update - Press Release
-
Trump says US, Canada will not restart trade talks
-
Fed's Logan says this week's rate cut was not needed, opposes one in December
-
Fed's Logan says opposed recent rate cut, questions December move
-
69% of consumers failed to reduce their debt last quarter, Achieve survey finds
-
CN Delivers Strong Third Quarter Financial and Operating Results
-
Novo Nordisk CEO says job cuts affecting 9,000 staff almost complete
-
US weekly jobless claims fall, economists estimate
-
DOGE to leave top US markets regulator, sources say
-
Amazon shares soar as cloud growth beats expectations
-
Fortune Brands Innovations Outperforms End Market with Sales Growth in Key Businesses
-
Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
-
Judge allows Trump administration to fire most of DOJ race-relations agency's employees
-
H.C. Wainwright Downgrades Sensei Biotherapeutics (SNSE) to Neutral
-
Backblaze and Dimensional Research Reveal Hidden Cost of Cloud Object Storage as Enterprises Confront AI Data Demands
-
Sensei Biotherapeutics discontinues drug development, explores sale
-
The AI hype check: Fortune companies are not hiring AI-ready workers
-
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value
-
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
-
Cushman & Wakefield Reports Financial Results for the Third Quarter 2025
-
Xerox Releases Third-Quarter Results
-
Struggling Puma vows to fight discounting, cut product range and boost brand
-
Asia Pacific Leads the World in AI Adoption While Grappling with Job Fears, BCG Survey Finds
-
Trading Day: Nvidia booms, Fed cools on easing
-
VIAVI Announces First Quarter Fiscal 2026 Results
-
Stem Announces Third Quarter 2025 Results
-
Align Technology Announces Third Quarter 2025 Financial Results
-
Cargill to lay off 80 workers in Minnesota, more globally
-
GM to cut EV, battery production and 1,200 jobs at Detroit plant
-
US pending home sales flat in September; job market worries likely dissuading buyers
-
FULL TEXT- Bank of Canada lowers key rate to 2.25%
-
FULL TEXT-Bank of Canada head says rate cut aimed at helping economy
-
Morning Bid: 48 hours to test the exuberance
-
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025
-
Adyen tops revenue estimates despite end of US tariff exemption for low-value packages
-
Mercedes beats auto margin estimates thanks to premium sales
